Drug for concussion, stroke found by UT scientist moves closer to human trials
Astrocyte Pharmaceuticals, the company Lechleiter founded with William Korinek of Boston, completed Monday its first round of financing that raised roughly $2.4 million in fresh capital. The fledgling company had $670,000 in seed funding from the federal government since 2014. Lechleiter hopes the drug, which is at least 7 years away from market, could be easily administered by any football coach or paramedic to mitigate the effects of concussions or strokes. Read more >>